Intellectual Property India Publishes Patent Application for Proteolysis-Targeting Chimera Tumor Vaccine

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617046193 A) filed by Trustees Of Tufts College on April 10, 2026, for Proteolysis-Targeting Chimera Tumor Vaccine.

Inventors include Xu, Qiaobing; and Zhao, Yu.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: Disclosed are compounds comprising an active agent covalently linked to a tumor antigen. Also disclosed herein nanoparticles comprising a tumor antigen covalently linked to an active agent and a plurality of lipid or lipidoids.

Disclaimer: Curated by HT Syndication.